This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Chemical Technology. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mi Hwa Kim and SARS-CoV-2 Vaccine Innovation.
Introduction
Mi Hwa Kim is an inventor associated with Daejeon, South Korea, and the Korea Research Institute of Chemical Technology. Her patent work includes a SARS-CoV-2 antigen and vaccine composition.
Latest Patents
Kim is listed as an inventor on one patent: “High-Potency SARS Coronavirus 2 Antigen and Vaccine Composition Comprising Same.” The invention concerns an antigen and vaccine composition designed to address SARS-CoV-2.
Career Highlights
Kim’s recorded patent activity connects her to research at the Korea Research Institute of Chemical Technology, a research institution based in South Korea. Her listed work focuses on vaccine-related innovation.
Collaborations
Kim is listed as a collaborator with Chonsaeng Kim on the patent concerning the SARS-CoV-2 antigen and vaccine composition.
Conclusion
Mi Hwa Kim’s patent record highlights her contribution to vaccine research through work on a SARS-CoV-2 antigen and vaccine composition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile